SYK - Stryker Corporation

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $385.83 DETAILS

Stock News

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

CHARLEVOIX, Mich.--(BUSINESS WIRE)--BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, Stryker (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in.

May 19, 2026 01:30 AM • businesswire.com

AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study

BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, today announced the enrollment of the first patient in its first-in-human (FIH) study for Pulsatile Intravascular Lithotripsy (PIVL) therapy in a coronary indication. The POWER CAD I study will evaluate the feasibility of the Pulse IVL™ System for the treatment of patients with moderate to severely calcified coronary arteri.

May 18, 2026 12:15 PM • businesswire.com

PAHC or SYK: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which of these two stocks is more attractive to value investors?

May 18, 2026 08:41 AM • zacks.com

Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom

Surgical robotics is quietly becoming an artificial intelligence story. Every robotic procedure generates structured video, kinematic, and outcomes data that platforms feed back into surgeon training, intraoperative guidance, and predictive analytics.

May 15, 2026 07:45 AM • 247wallst.com

Stryker Corporation (SYK) Presents at Bank of America Global Healthcare Conference 2026 Transcript

May 13, 2026 03:20 PM • seekingalpha.com

Is SYK Overvalued? DCF Says Worth $206

On May 12, 2026, we present a DCF analysis for Stryker Corp (SYK), a company that has faced notable price performance challenges recently, with a year-to-date d

May 12, 2026 03:32 AM • gurufocus.com

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease. “This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,” said Kevin Lobo, Chair and CEO, Stryker.

May 07, 2026 12:05 PM • globenewswire.com

Stryker declares an $0.88 per share quarterly dividend

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.

May 07, 2026 04:00 AM • globenewswire.com

Stock Of The Day: Is This The Bottom For Stryker?

Stryker Corporation (NYSE:SYK) shares are trading sideways on Monday. But that wasn't the case on Friday.

May 04, 2026 06:20 AM • benzinga.com

Stryker Q1 Earnings & Sales Miss Estimates on Cyber Disruption

SYK misses Q1 earnings and revenue estimates as a cyber incident disrupts production, dents margins, and slows growth despite gains across key segments.

May 01, 2026 07:31 AM • zacks.com

Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference

Portage, Michigan, May 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026, at the Encore at Wynn Hotel in Las Vegas, Nevada. Representing the company will be Spencer Stiles, President and Chief Operating Officer, Jason Beach, Vice President, Group Chief Financial Officer, MedSurg and Neurotechnology and Nick Mead, Vice President, Investor Relations.

May 01, 2026 04:00 AM • globenewswire.com

Stryker Corp (SYK) Q1 2026 Earnings Call Highlights: Navigating Cyber Challenges and Strategic Growth

Organic Sales Growth: 2.4% worldwide, 1.9% in the US, 3.9% internationally.Adjusted Earnings Per Share (EPS): $2.60, down 8.5% from the previous year.Adjusted

Apr 30, 2026 10:19 PM • gurufocus.com

Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript

Apr 30, 2026 08:41 PM • seekingalpha.com

Stryker (SYK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Stryker (SYK) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Apr 30, 2026 03:01 PM • zacks.com

Stryker (SYK) Q1 Earnings and Revenues Lag Estimates

Stryker (SYK) came out with quarterly earnings of $2.6 per share, missing the Zacks Consensus Estimate of $2.98 per share. This compares to earnings of $2.84 per share a year ago.

Apr 30, 2026 02:30 PM • zacks.com

Stryker misses quarterly estimates on muted demand for medical devices

U.S. medical device maker Stryker on Thursday maintained its full-year profit outlook but missed Wall Street estimates for first-quarter profit and revenue, weighed down by softer demand for implants ‌and devices used in complex procedures ranging from spinal to orthopedic surgeries.

Apr 30, 2026 01:40 PM • reuters.com

Stryker First-Quarter Sales, Profit Rise as it Dealt with Cyberattack

The medical-device company posted a profit of $745 million, up from $654 million in the same quarter a year ago.

Apr 30, 2026 12:33 PM • wsj.com

Stryker reports first quarter 2026 operating results

Portage, Michigan, April 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2026: First Quarter Results Reported net sales increased 2.6% to $6.0 billion Organic net sales increased 2.4% Reported operating income margin of 15.5% Adjusted operating income margin (1) contracted 180 bps to 21.1% Reported EPS increased 14.2% to $1.93 Adjusted EPS (1) decreased 8.5% to $2.60 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 5.0 % 1.4 % 3.6 % 2.7 % 0.9 % Orthopaedics 0.1 1.9 (1.8) (5.9) 4.1 Total 2.6 % 1.6 % 1.0 % (1.4) % 2.4 % “I am pleased with our team's ability to recover quickly from the cyber incident and continue delivering for our customers and their patients,” said Kevin A. Lobo, Chair and CEO.

Apr 30, 2026 12:05 PM • globenewswire.com

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Brad Saar joins Sonablate board to support growth of non-invasive prostate cancer treatment to signal next phase of expansion for HIFU-based prostate care.

Apr 30, 2026 05:03 AM • globenewswire.com